| Date | Time | Room | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|---|
| 13/04/2023 | 12:40 to 14:15 | Golden Hall |
Plenary Lecture - Prostate Module – Session: Metastatic Disease |
13:00 to 13:20 | Triplet versus doublet therapy in metastatic castration-sensitive prostate cancer | Speaker |
| 13/04/2023 | 12:40 to 14:15 | Golden Hall |
Plenary Lecture - Prostate Module – Session: Metastatic Disease |
13:20 to 13:25 | Discussion | Discussant |
| 13/04/2023 | 12:40 to 14:15 | Golden Hall |
Plenary Lecture - Prostate Module – Session: Metastatic Disease |
13:50 to 14:10 | Selecting and sequencing systemic treatments in castration-resistant prostate cancer | Speaker |
| 13/04/2023 | 12:40 to 14:15 | Golden Hall |
Plenary Lecture - Prostate Module – Session: Metastatic Disease |
14:10 to 14:15 | Discussion | Discussant |
| 13/04/2023 | 15:30 to 16:20 | Golden Hall |
Plenary Lecture - Prostate Module – Session: Metastatic Disease |
15:30 to 15:50 | Novel molecular and clinical progress helping the choice of the best treatment for metastatic castration-sensitive prostate cancer | Speaker |
| 13/04/2023 | 15:30 to 16:20 | Golden Hall |
Plenary Lecture - Prostate Module – Session: Metastatic Disease |
15:50 to 15:55 | Discussion | Discussant |
| 13/04/2023 | 17:20 to 18:10 | Golden Hall |
Plenary Lecture - Clinical cases discussion: metastatic prostate cancer |
Discussant | ||
| 14/04/2023 | 08:00 to 10:05 | Golden Hall |
Plenary Lecture - Bladder Module - Session: Localized Disease |
09:15 to 09:35 | Future directions for bladder-preserving treatment and for diagnosis of urothelial cancer | Speaker |
| 14/04/2023 | 08:00 to 10:05 | Golden Hall |
Plenary Lecture - Bladder Module - Session: Localized Disease |
09:35 to 09:40 | Discussion | Discussant |
| 14/04/2023 | 16:20 to 17:20 | Golden Hall |
Plenary Lecture - Clinical cases discussion: bladder cancer |
Discussant |